Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;45(5):999-1009.
doi: 10.1007/s40618-021-01735-w. Epub 2022 Jan 6.

PI3K inhibition by BKM120 results in anti-proliferative effects on corticotroph tumor cells

H A Oliveira  1 , A C Bueno  2 , R S Pugliesi  1 , R M P da Silva Júnior  1 , M de Castro  1 , C S Martins  3
Affiliations

PI3K inhibition by BKM120 results in anti-proliferative effects on corticotroph tumor cells

H A Oliveira et al. J Endocrinol Invest. 2022 May.

Abstract

Purpose: Cushing's disease is associated with significant morbidity; thus, additional tumor-directed drugs with the potential to exert antineoplastic effects on corticotroph adenoma cells are desired. The phosphoinositide-3-kinase (PI3K)/protein kinase B (AKT) pathway, which plays regulatory role in cell survival and proliferation, is activated in pituitary adenomas. The present study evaluated the effects of BKM120 (Buparlisib), an oral PI3K inhibitor, on cell viability, apoptosis, cell cycle phase distribution, and ACTH production in mouse corticotroph tumor cells.

Methods: AtT-20/D16v-F2 mouse pituitary corticotroph tumor cells were treated with increasing concentrations of BKM120 or vehicle. Cell viability was measured using an MTS-based assay. Apoptosis was evaluated by Annexin V staining. Cell cycle analysis was performed by propidium iodide DNA staining and flow cytometry. Gene expression of cell cycle regulators (Cdkn1b, Ccnd1, Ccne1, Cdk2, Cdk4, Myc, and Rb1) was assessed by qPCR. Protein expression of p27, total and phosphorylated Akt was assessed by Western blot. ACTH levels were measured in the culture supernatants by chemiluminescent immunometric assay.

Results: Treatment with BKM120 decreased AtT-20/D16v-F2 cell viability, induced a G0/G1 cell cycle arrest, reduced the phosphorylation of Akt at Serine 473, and increased p27 expression. Furthermore, BKM120 treatment diminished ACTH levels in the cell culture supernatants.

Conclusion: In vitro inhibition of PI3K/AKT pathway by BKM120 resulted in anti-proliferative effects on corticotroph tumor cells, decreasing cell viability and ACTH production. These encouraging findings shape the path for further experiments with the inhibition of PI3K/AKT pathway in Cushing's disease.

Keywords: AKT; Corticotroph adenoma; Cushing’s disease; PI3K.

PubMed Disclaimer

References

    1. Nieman LK, Biller BMK, Findling JW et al (2015) Treatment of cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 100:2807–2831. https://doi.org/10.1210/jc.2015-1818 - DOI - PubMed - PMC
    1. Pivonello R, De Leo M, Cozzolino A, Colao A (2015) The treatment of Cushing’s disease. Endocr Rev 36:385–486. https://doi.org/10.1210/er.2013-1048 - DOI - PubMed - PMC
    1. Ferriere A, Tabarin A (2020) Cushing’s syndrome: treatment and new therapeutic approaches. Best Pract Res Clin Endocrinol Metab 34:101381. https://doi.org/10.1016/j.beem.2020.101381 - DOI - PubMed
    1. Pivonello R, Ferrigno R, De Martino MC et al (2020) Medical treatment of Cushing’s disease: an overview of the current and recent clinical trials. Front Endocrinol 11:648. https://doi.org/10.3389/fendo.2020.00648 - DOI
    1. Pivonello R, Fleseriu M, Newell-Price J et al (2020) Efficacy and safety of osilodrostat in patients with Cushing’s disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase. Lancet Diabetes Endocrinol 8:748–761. https://doi.org/10.1016/S2213-8587(20)30240-0 - DOI - PubMed

LinkOut - more resources